Literature DB >> 19488795

MAGE-A antigens in patients with primary oral squamous cell carcinoma.

Urs D A Müller-Richter1, Albert Dowejko, Silvia Peters, Stephan Rauthe, Tobias Reuther, Stefan Gattenlöhner, Torsten E Reichert, Oliver Driemel, Alexander C Kübler.   

Abstract

MAGE-A antigens are only expressed on tumor cells. The aim of this study was to identify their expression in patients with oral squamous cell carcinoma (OSCC). Forty-seven patients with primary OSCC was selected retrospectively. Histo-pathological sections were stained immunohistochemically with MAGE-A antibody 57B. The results were evaluated regarding tumor size (T), lymph-node metastasis (N), blood vessel infiltration (V), lymph vessel infiltration (L), grading (G), and sex. MAGE-A antigens were expressed in 55% of all patients. Expression increased with tumor size (T1 = 56%; T2 = 44%; T3 = 67%; T4 = 71%). Lymph-node metastasis had no influence (N0 and N1 about 50%). Tumors with blood and lymph vessel infiltration had higher expression (V0 = 50%; V1 = 100%; L0 = 46%; L1 = 71%). Less-differentiated tumors showed higher rates (G1 = 50%; G2 = 45%; G3 = 83%). OSCC in men were positive in 62% and in women in 38%. MAGE-A antigens are frequently expressed in OSCC. Their expression seems to increase with tumor dedifferentiation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19488795     DOI: 10.1007/s00784-009-0292-2

Source DB:  PubMed          Journal:  Clin Oral Investig        ISSN: 1432-6981            Impact factor:   3.573


  25 in total

1.  Expression of cancer-testis antigens as possible targets for antigen-specific immunotherapy in head and neck squamous cell carcinoma.

Authors:  Djordje Atanackovic; Inga Blum; Yanran Cao; Sören Wenzel; Katrin Bartels; Christiane Faltz; Dieter Kurt Hossfeld; Susanna Hegewisch-Becker; Carsten Bokemeyer; Rudolf Leuwer
Journal:  Cancer Biol Ther       Date:  2006-09-09       Impact factor: 4.742

2.  Tissue microarray evaluation of Melanoma antigen E (MAGE) tumor-associated antigen expression: potential indications for specific immunotherapy and prognostic relevance in squamous cell lung carcinoma.

Authors:  Martin Bolli; Thomas Kocher; Michel Adamina; Ulrich Guller; Peter Dalquen; Philippe Haas; Martina Mirlacher; Franco Gambazzi; Felix Harder; Michael Heberer; Guido Sauter; Giulio C Spagnoli
Journal:  Ann Surg       Date:  2002-12       Impact factor: 12.969

3.  Cancer-testis antigens: expression and correlation with survival in human urothelial carcinoma.

Authors:  Padmanee Sharma; Yu Shen; Sijin Wen; Dean F Bajorin; Victor E Reuter; Lloyd J Old; Achim A Jungbluth
Journal:  Clin Cancer Res       Date:  2006-09-15       Impact factor: 12.531

4.  Investigation of the expression of melanoma antigen-encoding genes (MAGE-A1 to -A6) in oral squamous cell carcinomas to determine potential targets for gene-based cancer immunotherapy.

Authors:  Jutta Ries; Stefan Schultze-Mosgau; Friedrich Neukam; Elke Diebel; Joerg Wiltfang
Journal:  Int J Oncol       Date:  2005-03       Impact factor: 5.650

5.  Expression of MAGE A 1-6 mRNA in sputa of head and neck cancer patients--a preliminary report.

Authors:  Kang Dae Lee; Hwan Ho Lee; Ho Bum Joo; Hyoung Shin Lee; Tai Hyun Yu; Hee Kyung Chang; Chang Ho Jeon; Jong Wook Park
Journal:  Anticancer Res       Date:  2006 Mar-Apr       Impact factor: 2.480

6.  Expression of MAGE genes in primary and metastatic cutaneous melanoma.

Authors:  F Brasseur; D Rimoldi; D Liénard; B Lethé; S Carrel; F Arienti; L Suter; R Vanwijck; A Bourlond; Y Humblet
Journal:  Int J Cancer       Date:  1995-11-03       Impact factor: 7.396

7.  Expression of cancer/testis tumor associated antigens in cervical squamous cell carcinoma.

Authors:  Bozena Sarcevic; Giulio C Spagnoli; Luigi Terracciano; Elke Schultz-Thater; Michael Heberer; Marija Gamulin; Zdenko Krajina; Tomislav Oresic; Robert Separovic; Antonio Juretic
Journal:  Oncology       Date:  2003       Impact factor: 2.935

8.  Melanoma-associated antigen-A1 expression predicts resistance to docetaxel and paclitaxel in advanced and recurrent gastric cancer.

Authors:  Takahisa Suzuki; Kazuhiro Yoshida; Yoshiyuki Wada; Yoichi Hamai; Kazuhiro Sentani; Naohide Oue; Wataru Yasui
Journal:  Oncol Rep       Date:  2007-08       Impact factor: 3.906

9.  Expression of cancer testis antigens in head and neck squamous cell carcinomas.

Authors:  David L A Figueiredo; Rui C M Mamede; Rodrigo Proto-Siqueira; Luciano Neder; Wilson A Silva; Marco A Zago
Journal:  Head Neck       Date:  2006-07       Impact factor: 3.147

Review 10.  Recent advances in Oral Oncology 2007: imaging, treatment and treatment outcomes.

Authors:  Crispian Scully; Jose V Bagan
Journal:  Oral Oncol       Date:  2008-02-07       Impact factor: 5.337

View more
  4 in total

1.  MAGE-A antigens in lesions of the oral mucosa.

Authors:  Eva Krauss; Stephan Rauthe; Stefan Gattenlöhner; Tobias Reuther; Michael Kochel; Ulrike Kriegebaum; Alexander C Kübler; Urs D A Müller-Richter
Journal:  Clin Oral Investig       Date:  2010-02-20       Impact factor: 3.573

2.  Correlation of MAGE-A tumor antigens and the efficacy of various chemotherapeutic agents in head and neck carcinoma cells.

Authors:  S Hartmann; U Kriegebaum; N Küchler; R C Brands; C Linz; A C Kübler; U D A Müller-Richter
Journal:  Clin Oral Investig       Date:  2013-02-21       Impact factor: 3.573

3.  MAGE-A11 expression contributes to cisplatin resistance in head and neck cancer.

Authors:  Stefan Hartmann; Leonie Zwick; Mario J J Scheurer; Andreas R Fuchs; Roman C Brands; Axel Seher; Hartmut Böhm; Alexander C Kübler; Urs D A Müller-Richter
Journal:  Clin Oral Investig       Date:  2017-10-15       Impact factor: 3.573

4.  MAGE-A as a novel approach in the diagnostic accuracy of oral squamous cell cancer: a case report.

Authors:  Philipp Metzler; Nur Mollaoglu; Stephan Schwarz; Friedrich W Neukam; Emeka Nkenke; Jutta Ries
Journal:  Head Neck Oncol       Date:  2009-12-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.